{"target_list": {"GB Holdings Limited": {"source_list": [{"holder": "1", "name": "普生股份有限公司"}], "taxcode": "NA"}, "Pacgen Life Science Corporation": {"source_list": [{"holder": "0", "name": "居禮股份有限公司"}, {"holder": "0", "name": "普生股份有限公司"}], "taxcode": "NA"}, "普生股份有限公司": {"source_list": [{"holder": "NA", "name": "英屬維京群島商長青盈有限公司"}, {"holder": "NA", "name": "英屬維京群島商頂榮有限公司"}, {"holder": "NA", "name": "德慧國際股份有限公司"}], "taxcode": "47299918"}, "Xphase Pharmaceuticals Inc.": {"source_list": [{"holder": "0", "name": "Pacgen Life Science Corporation"}], "taxcode": "NA"}, "Pacgen Inc.": {"source_list": [{"holder": "1", "name": "普生股份有限公司"}], "taxcode": "NA"}, "IL Therapeutics Inc.": {"source_list": [{"holder": "0", "name": "Pacgen Life Science Corporation"}], "taxcode": "NA"}, "Danner Laboratory Inc.": {"source_list": [{"holder": "1", "name": "GB Holdings Limited"}], "taxcode": "NA"}, "Pacgen Biomedical Inc.": {"source_list": [{"holder": "1", "name": "普生股份有限公司"}], "taxcode": "NA"}, "居禮股份有限公司": {"source_list": [{"holder": "1", "name": "普生股份有限公司"}], "taxcode": "97120902"}}, "company_list": [{"taxcode_source": "NA", "target": "Danner Laboratory Inc.", "has_fine": false, "source": "GB Holdings Limited", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "47299918", "target": "GB Holdings Limited", "has_fine": false, "source": "普生股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "NA", "target": "IL Therapeutics Inc.", "has_fine": false, "source": "Pacgen Life Science Corporation", "holder": "0", "taxcode_target": "NA"}, {"taxcode_source": "47299918", "target": "Pacgen Biomedical Inc.", "has_fine": false, "source": "普生股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "47299918", "target": "Pacgen Inc.", "has_fine": false, "source": "普生股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "97120902", "target": "Pacgen Life Science Corporation", "has_fine": false, "source": "居禮股份有限公司", "holder": "0", "taxcode_target": "NA"}, {"taxcode_source": "47299918", "target": "Pacgen Life Science Corporation", "has_fine": false, "source": "普生股份有限公司", "holder": "0", "taxcode_target": "NA"}, {"taxcode_source": "NA", "target": "Xphase Pharmaceuticals Inc.", "has_fine": false, "source": "Pacgen Life Science Corporation", "holder": "0", "taxcode_target": "NA"}, {"taxcode_source": "47299918", "target": "居禮股份有限公司", "has_fine": false, "source": "普生股份有限公司", "holder": "1", "taxcode_target": "97120902"}, {"taxcode_source": "NA", "target": "普生股份有限公司", "has_fine": false, "source": "英屬維京群島商長青盈有限公司", "holder": "NA", "taxcode_target": "47299918"}, {"taxcode_source": "NA", "target": "普生股份有限公司", "has_fine": false, "source": "英屬維京群島商頂榮有限公司", "holder": "NA", "taxcode_target": "47299918"}, {"taxcode_source": "23640056", "target": "普生股份有限公司", "has_fine": false, "source": "德慧國際股份有限公司", "holder": "NA", "taxcode_target": "47299918"}], "company_summery": {"has_fine": true, "fine_penalty_amount": 60000, "company_amount": 12, "group_name": "普生", "fine_record_num": 1, "group_no": "G4117", "fine_company_amount": 1}, "fine_company_list": [{"penalty_amount": 60000, "fine_num": 1, "name": "普生股份有限公司", "taxcode": "47299918"}]}